U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
XELIGEKIMAB
INN  
Official Name English
GR-1501
Preferred Name English
Xeligekimab [WHO-DD]
Common Name English
xeligekimab [INN]
Common Name English
GR1501
Common Name English
IMMUNOGLOBULIN G4 (235-PROLINE), ANTI-(HUMAN INTERLEUKIN 17A) (HUMAN MONOCLONAL GR1501 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL GR1501 .KAPPA.-CHAIN, DIMER
Common Name English
Code System Code Type Description
NCI_THESAURUS
C188599
Created by admin on Wed Apr 02 12:34:54 GMT 2025 , Edited by admin on Wed Apr 02 12:34:54 GMT 2025
PRIMARY
INN
11625
Created by admin on Wed Apr 02 12:34:54 GMT 2025 , Edited by admin on Wed Apr 02 12:34:54 GMT 2025
PRIMARY
FDA UNII
MC5WXU879E
Created by admin on Wed Apr 02 12:34:54 GMT 2025 , Edited by admin on Wed Apr 02 12:34:54 GMT 2025
PRIMARY
SMS_ID
300000039104
Created by admin on Wed Apr 02 12:34:54 GMT 2025 , Edited by admin on Wed Apr 02 12:34:54 GMT 2025
PRIMARY
CAS
2382921-73-3
Created by admin on Wed Apr 02 12:34:54 GMT 2025 , Edited by admin on Wed Apr 02 12:34:54 GMT 2025
PRIMARY
ACTIVE MOIETY
XELIGEKIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966